In this study, we retrospectively analyzed HR expression and Ki67 in specimens of core needle biopsy (CB) and excised tissue biopsy (EB) from 525 breast cancer patients who received neoadjuvant chemotherapy and evaluated the impact of neoadjuvant chemotherapy on the expression of these two biomarkers. Here, MKI67 is linked to breast carcinoma.